MTOR and non-small cell lung carcinoma: GOLPH3 is found to act as a key factor in mTOR activation in the non‐small cell lung carcinoma (NSCLC), which is ascribed to the correlation of 5p amplification with the increased phosphorylation of mTOR substrate.8